Clinical Trials Browser

Phase 1 × Active not recruiting × ixazomib × Clear all

NCT03283917 2026-02-27

Daratumumab, Ixazomib, and Dexamethasone in AL Amyloidosis

Phase 1 Active not recruiting

Immunoglobulin Light-chain Amyloidosis